Patent · US Active

Stable formulations for lyophilizing therapeutic particles

US9872848B2 · kind B2 · utility

2Cited by
38References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2016
Grant dateJan 23, 2018
Priority date
Expiry dateOct 18, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/906
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.